title: Would riluzole be efficacious in the new ALS trial design?
authors.forename: Esther
authors.initials: E
authors.lastname: Verstraete
authors.forename: Jan H
authors.initials: JH
authors.lastname: Veldink
authors.forename: Leonard H
authors.initials: LH
authors.lastname: van den Berg
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D018849:Controlled Clinical Trials as Topic / Q000379:methods* / Q000639:trends; D006801:Humans; D010865:Pilot Projects; D019782:Riluzole / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019782:Riluzole